Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
批准号:
10274338
负责人:
Charlie Fehl
金额:
$35.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2026-04-30
关键词:
AddressAwarenessBiologyBreast Cancer Risk FactorCell NucleusCellsCellular Metabolic ProcessChemicalsCommunitiesCytosolDevelopmentDiabetes MellitusDiseaseDisease PathwayDrug TargetingEndoplasmic ReticulumEnsureEventFundingGlucoseGlycobiologyGoalsHourHumanHyperglycemiaIncidenceIndustrializationInflammationInsulinKnowledgeLabelLaboratoriesLeadLinkLocationMalignant NeoplasmsMapsMetabolicMetabolic DiseasesMetabolismMethodsModificationMolecularMolecular ProbesMorphologic artifactsMovementNon-Insulin-Dependent Diabetes MellitusNutrientOncogenicOutputPathologyPatientsPhotochemistryPhysiologic pulsePhysiologicalPhysiologyPost-Translational Protein ProcessingProcessProteinsPublishingReal-Time SystemsReportingResearchResolutionScientistSialic AcidsSignal TransductionSpecialistStressSubcellular SpacesSystemTherapeuticTimeUnited States National Institutes of HealthWorkcancer riskdiabetic patientdisorder riskhuman diseaseinnovationinsulin signalinglink proteinmalignant breast neoplasmprogramspublic health relevancespatiotemporalsuccesssugartechnology developmenttooltranscription factortumor metabolism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The overall goal of the Fehl laboratory is to develop chemical biology strategies to determine the functional
impact of protein modifications during signaling processes. Specifically, cellular metabolism and stress each lead
to diverse protein modifications with O-linked N-acetylglucosamine sugar (O-GlcNAc) but no tools are currently
able to capture highly dynamic and transient O-GlcNAc events with defined time and spatial resolution. Lack of
“time and space” rigor hinders the scientific community from connecting metabolism with disease physiology,
including significantly elevated cancer risk in diabetic patients observed for malignancies like breast cancer.
In this MIRA application, we pose our strategies to address this critical gap through the development of real-time
and space molecular tools that bridge cell metabolism and cancer processes using O-GlcNAc as the keystone.
Excellent NIH-funded research has discovered over 2000 O-GlcNAc on proteins in human cells, but current tools
rely on disrupted physiology, leading to artifacts, or miss key GlcNAc-driven signaling events that occur before
global metabolic rebalancing occurs in less than an hour. We hypothesize that the key drivers of hyperglycemic
metabolism and pathology lie within the first few minutes of nutrient and signaling stimulation, which to date is
not possible to observe in living cells. Our published work in photochemistry and systems glycobiology support
our unique strategies to trigger O-GlcNAc processes in minutes, before O-GlcNAc rebalancing occurs. Our
photocaged sugar tool is able to trigger the oncogenic transcription factor NFkB movement between cytosol or
endoplasmic reticulum into the nucleus, simulating physiological events that potentially link aberrant insulin and
glucose release in diabetes with breast cancer risk. Our real time system can be used to track O-GlcNAc events
during insulin signaling for the first time during the rapid, 15-minute pulses of diseased insulin physiology.
Another tool for targeted intracellular O-GlcNAc-targeted proximity labeling is able to track O-GlcNAcylated
proteins in subcellular space, which no reported tool has the capability to specifically label in live cells. We
propose in the next 5 years to develop our “time and space” molecular tools and apply them for unique
mechanistic studies in disease biology through NFkB targeting. We actively collaborate with metabolic disease
and cancer specialists to ensure disease relevance, as well as with industrial scientists for technology
development to expand industrial awareness of O-GlcNAc biology in metabolism-driven disease pathways.
The research outputs of this proposal include molecular probes, spatiotemporal strategies, and targets to
connect cellular metabolism with signaling. Our enabling chemical strategies have the potential for broad impact
in the scientific community by establishing temporal and spatial methods to study protein modifications. Our
platforms can be extended to other PTMs and drug targets, such as sialic acid modifications that regulate the
interface of cancer metabolism and inflammation. Success will establish a lasting independent research niche.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
-
批准号:10605263
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2021
-
负责人:Charlie Fehl
-
依托单位:
Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
-
批准号:10414136
-
项目类别:
-
资助金额:$36.57万
-
财政年份:2021
-
负责人:Charlie Fehl
-
依托单位:
Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
-
批准号:10514088
-
项目类别:
-
资助金额:$4.67万
-
财政年份:2021
-
负责人:Charlie Fehl
-
依托单位:
Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
-
批准号:10796196
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2021
-
负责人:Charlie Fehl
-
依托单位:
Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling
-
批准号:10728390
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2021
-
负责人:Charlie Fehl
-
依托单位:
海外基金